Explicit
THE FIRST MAJOR DEVELOPMENT IN 20 YEARS TO HELP MANAGE CHRONIC KIDNEY DISEASE...
Jul 20, 2021 ·
7m 35s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
IN PATIENTS AT RISK OF PROGRESSION WITH AND WITHOUT TYPE 2 DIABETES Chronic kidney disease (CKD) is a life-threatening disease that is vastly underdiagnosed and affects an estimated 37 million,...
show more
IN PATIENTS AT RISK OF PROGRESSION WITH AND WITHOUT TYPE 2 DIABETES
Chronic kidney disease (CKD) is a life-threatening disease that is vastly underdiagnosed and affects an estimated 37 million, or 1 in 7, American adults.[1][2] With limited treatment options available, a new therapy is critical for people living with CKD to help slow disease progression – which is why...
for video and more info, go to http://goodnewsplanet.com/the-first-major-development-in-20-years-to-help-manage-chronic-kidney-disease-in-patients-at-risk-of-progression-with-and-without-type-2-diabetes/
#astrazeneca #kidney #disease #health #chronic #patient #risk #diabetes #treatment #therapy #heart #ckd #neil #skolnik #thomas #jefferson #medicine #medical #family #factors
show less
Chronic kidney disease (CKD) is a life-threatening disease that is vastly underdiagnosed and affects an estimated 37 million, or 1 in 7, American adults.[1][2] With limited treatment options available, a new therapy is critical for people living with CKD to help slow disease progression – which is why...
for video and more info, go to http://goodnewsplanet.com/the-first-major-development-in-20-years-to-help-manage-chronic-kidney-disease-in-patients-at-risk-of-progression-with-and-without-type-2-diabetes/
#astrazeneca #kidney #disease #health #chronic #patient #risk #diabetes #treatment #therapy #heart #ckd #neil #skolnik #thomas #jefferson #medicine #medical #family #factors
Information
| Author | Paul Sladkus |
| Organization | Paul Sladkus |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
